For Research Use Only. We do not provide services or products directly for patients.
Product Overview
SARS-CoV-2 (2019-nCoV), Expression Plasmid, High Copy, contains surface glycoprotein gene integrated with eGFP through linker.
Promoter
CMV promoter
Tag
eGFP
Vector
pcDNA3.1(+)-C-eGFP
Target
SARS-CoV-2
Length
9931
Bacterial Resistance
Ampicillin
Product Form
Lyophilized
Applications
Used for gene expression and flow cytometry antibody screening or immunological research.
Storage
Ambient temperature
Introduction
The 2019 novel coronavirus, or "SARS-CoV-2", was discovered because of Wuhan virus pneumonia cases in 2019, and was named by the World Health Organization on January 12, 2020. It belongs to the beta genera of the Coronaviridae family, together with SARS coronavirus in 2003 and MERS coronavirus in 2012. The alignment between SARS-CoV-2 and 2003 SARS CoV has about 70% sequence similarity and 40% sequence similarity with MERS CoV. The coronavirus genome encodes a spike protein, an envelope protein, a membrane protein, and a nucleoprotein. Among them, spike protein is the most important surface membrane protein of coronavirus.